tsh biopharmoration Ltd (8432) — Cash Flow Reinvestment Rate
tsh biopharmoration Ltd (8432) has a Cash Flow Reinvestment Rate of 0.08x as of June 2025, reinvesting NT$3.27 Million (capex NT$3.27 Million ) from operating cash flow of NT$42.55 Million. Explore tsh biopharmoration Ltd (8432) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
tsh biopharmoration Ltd Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for tsh biopharmoration Ltd across 8 annual periods. Also explore 8432 asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for tsh biopharmoration Ltd (2017–2024)
Year-by-year capital reinvestment analysis for tsh biopharmoration Ltd. For live market cap and broader valuation context, see tsh biopharmoration Ltd (8432) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.71x | NT$130.68 Million | NT$183.77 Million | NT$2.74 Million | ▼ -85.5% |
| 2023 | 4.92x | NT$166.57 Million | NT$33.87 Million | NT$5.56 Million | ▲ +297.7% |
| 2022 | 1.24x | NT$42.48 Million | NT$34.35 Million | NT$18.73 Million | ▲ +479.4% |
| 2021 | 0.21x | NT$14.66 Million | NT$68.71 Million | NT$382.00K | ▼ -98.9% |
| 2020 | 19.96x | NT$231.81 Million | NT$11.61 Million | NT$2.38 Million | ▲ +7837.8% |
| 2019 | 0.25x | NT$22.30 Million | NT$88.65 Million | NT$3.00 Million | ▼ -90.3% |
| 2018 | 2.59x | NT$162.16 Million | NT$62.62 Million | NT$5.88 Million | ▲ +74.7% |
| 2017 | 1.48x | NT$120.29 Million | NT$81.13 Million | NT$4.57 Million | — |